| Autor: |
A, Tanguy-Schmidt, M, Avenel-Audran, A, Croué, S, Lissandre, M, Dib, M, Zidane-Marinnes, M-P, Moles, M, Hunault-Berger |
| Jazyk: |
francouzština |
| Rok vydání: |
2008 |
| Předmět: |
|
| Zdroj: |
Annales de dermatologie et de venereologie. 136(5) |
| ISSN: |
0151-9638 |
| Popis: |
Bortezomid is a potent proteasome inhibitor used in patients with relapsing or refractory multiple myeloma and provides a 35% response with a median duration of response of 12 months. Numerous adverse effects are known, mainly comprising haematological and neurological complications. A wide variety of cutaneous complications have also been described in 10 to 20% of patients.We report a case of bortezomib-induced Sweet syndrome. The diagnostic criteria required for drug-induced Sweet syndrome were present.The importance of this description is that this induced Sweet syndrome may not necessarily require cessation of bortezomid since administration of corticosteroids prevents its recurrence. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect